000 01850nam a2200409 i 4500
001 ocn976178012
003 OCoLC
005 20180416115119.0
007 he bmb024bbca
008 170316s2017 dcu b f000 0 eng c
040 _aPTL
_beng
_erda
_cPTL
_dOCLCQ
_dNTE
_dGPO
_dMvI
042 _apcc
043 _an-us---
050 1 4 _aKF32
_b.E55 2016zd
074 _a1008-D (MF)
086 0 _aY 1.1/8:114-672
099 _aY 1.1/8:114-672
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Energy and Commerce,
_eauthor.
245 1 0 _aDXM Abuse Prevention Act of 2015 :
_breport (to accompany H.R. 3250) (including cost estimate of the Congressional Budget Office).
264 1 _a[Washington, D.C.] :
_b[U.S. Government Publishing Office],
_c[2016]
300 _a26 pages ;
_c24 cm.
336 _atext
_btxt
_2rdacontent
337 _amicroform
_bh
_2rdamedia
338 _amicrofiche
_bhe
_2rdacarrier
490 1 _aReport / 114th Congress, 2d session, House of Representatives ;
_v114-672
500 _a"July 8, 2016."
500 _aShipping list no.: 2016-0248-M.
500 _aCRDP Program record.
533 _aMicrofiche.
_b[Washington, D.C.] :
_cU.S. Government Printing Office,
_d[2018]
_e1 microfiche : negative.
650 0 _aDextromethorphan
_xLaw and legislation
_zUnited States.
650 0 _aDrug abuse
_xLaw and legislation
_zUnited States.
650 0 _aPharmacy
_xLaw and legislation
_zUnited States.
655 7 _aLegislative materials.
_2lcgft
776 0 8 _iOnline version:
_aUnited States. Congress. House. Committee on Energy and Commerce.
_tDXM Abuse Prevention Act of 2015
_w(OCoLC)953525232
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Energy and Commerce.
_tDXM Abuse Prevention Act of 2015
_w(OCoLC)953798820
810 1 _aUnited States.
_bCongress.
_bHouse.
_tReport ;
_v114-672.
999 _c270694
_d270694